We further found that four MRGs (BCL2L11, NAGS, RMND1, and HDHD3) were overlapped among the three models, which were finally considered as the potential diagnostic biomarkers for NAFLD (Fig. 5D). This evidence concerns the gene BCL2L11 and metabolic dysfunction-associated steatotic liver disease.